Skip to content

enVista® Toric IOL MX60PT (REF MXUPT125+240)Recalls & reported problems

Bausch & Lomb Incorporated · enVista one-piece hydrophobic acrylic toric intraocular lens (preloaded) +24.00D SE / +1.25D CYL · Class 3 · Implant

All models of enVista Toric IOL (450)

Data updated Oct 18, 2026 from official FDA records · Editorial policy

Adverse event reports
1
Deaths reported
0
Injuries reported
1
Recalls naming it
0

Summary

The FDA's MAUDE database contains 1 adverse event report that list this exact device (DI 10757770566508), received between May 12, 2023 and May 12, 2023 — classified as 1 injury.

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.

Most reported problems

Device problems

  • Adverse Event Without Identified Device or Use Problem1

Patient problems

  • Blurred Vision1
  • Excessive Tear Production1
  • Halo1

Recent adverse event reports

The 1 most recent of 1 reports, in the reporter's own words as published by the FDA.

  • InjuryMay 12, 2023Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem

    ADDITIONAL INFORMATION WAS RECEIVED INDICATING AN UNVALIDATED INJECTOR WAS USED TO COMPLETE THIS SURGERY. ALSO THE OUTCOME ACCORDING TO THE SURGEON WAS SUBJECTIVE AND THERE WAS NO ISSUES REPORTED WITH THE LENS. IT IS NOTEWORTHY TO MENTION THAT THE REPLACEMENT IOL WAS OF A DIFFERENT MODEL AND DIOPTER.

    Patient problems: Blurred Vision; Excessive Tear Production; Halo

    MAUDE report 16918739 ↗

Other intraocular lens devices

All intraocular lens devices →

Sources and updates

How reports and recalls are matched · Editorial policy · Report an error on this page